calendar
7,525 catalysts · 3,350 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k
next 91 dayslessmore
MonWedFri
7,525 catalysts · 3,350 8k filing · 1,096 grant · 1,000 device adverse event · 580 earnings · 550 approval · 430 device 510k
Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30
Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30
Supplement type: 30-Day Notice. Product code: OWD. Advisory committee: PA. Decision: OK30
Custom Abutment Ti, for Straumann RC, incl. TAN screw; Catalog Number/Art.: 027.4620; — Reason: A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr4 D (SAP #701922 / Lot 7130430). As a result, RC Titanium abutments were manufactured using the TAN Bar material on Mill-from-Bar Machine 396-06. — Status: Ongoing
Custom Abutment AS Ti, for Straumann RC, incl. TAN screw; Catalog Number/Art.: 010.5438; — Reason: A material mix-up had occurred during the manufacturing of Straumann¿ Custom Abutments. More specifically, a raw material bar of TAN-material (SAP #701924 / Lot 7130439) was incorrectly identified as a Titanium Bar Ti Gr4 D (SAP #701922 / Lot 7130430). As a result, RC Titanium abutments were manufactured using the TAN Bar material on Mill-from-Bar Machine 396-06. — Status: Ongoing
HL grant. $29,270. PI: Lillian Hyde
GM grant. $510,183. PI: Yun S Song
NS grant. $744,451. PI: Ruchira Singh
DK grant. $821,618. PI: Steven D Crowley
MH grant. $1,177,156. PI: Thibaut Davy-Mendez
NS grant. $122,769. PI: Yichen Luo
HL grant. $4,750. PI: Lillian Hyde
EB grant. $39,349. PI: Kelly Anne Burke
NS grant. $716,816. PI: Amar Dhand
NS grant. $461,197. PI: David Pitt
NS grant. $632,144. PI: Aaron Mark Gusdon
NS grant. $471,861. PI: David Christopher Martinelli
Sponsor: PH HEALTH. Form: FOR SOLUTION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC
Sponsor: FONSECA BIOSCIENCES. Form: SUSPENSION/DROPS. Route: OTIC
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: ACTAVIS. Form: INJECTABLE. Route: INJECTION
Sponsor: ACTAVIS LABS FL INC. Form: CAPSULE. Route: ORAL
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: ACCORD HLTHCARE. Form: FOR SOLUTION. Route: ORAL
Sponsor: ASCENT PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION
Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: DR REDDYS. Form: FOR SOLUTION. Route: ORAL
Sponsor: SOBI. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: GEL. Route: TOPICAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: UNIQUE. Form: TABLET. Route: ORAL
Sponsor: MSN. Form: FOR SOLUTION. Route: ORAL
Sponsor: PROVEPHARM SAS. Form: INJECTABLE. Route: INJECTION
Sponsor: AMNEAL PHARMS. Form: FOR SOLUTION. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: FOR SOLUTION. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL
Sponsor: DR REDDYS. Form: TABLET. Route: ORAL
Sponsor: PYROS PHARMS. Form: FOR SOLUTION. Route: ORAL
Sponsor: LUNDBECK PHARMS LLC. Form: FOR SOLUTION. Route: ORAL
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION